Cypress Capital Management LLC (WY) - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 146 filers reported holding CLOVIS ONCOLOGY INC in Q4 2014. The put-call ratio across all filers is 0.43 and the average weighting 0.7%.

Quarter-by-quarter ownership
Cypress Capital Management LLC (WY) ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q2 2022$0
-100.0%
200
-90.0%
0.00%
-100.0%
Q1 2022$4,000
-20.0%
2,0000.0%0.01%
+25.0%
Q4 2021$5,000
-44.4%
2,0000.0%0.00%
-42.9%
Q3 2021$9,000
-25.0%
2,0000.0%0.01%
-22.2%
Q2 2021$12,000
-14.3%
2,0000.0%0.01%
-25.0%
Q1 2021$14,000
+40.0%
2,0000.0%0.01%
+33.3%
Q4 2020$10,000
-9.1%
2,0000.0%0.01%
-10.0%
Q3 2020$11,000
-67.6%
2,000
-60.0%
0.01%
-70.6%
Q2 2020$34,000
+161.5%
5,000
+150.0%
0.03%
+88.9%
Q1 2020$13,000
-38.1%
2,0000.0%0.02%
-10.0%
Q4 2019$21,000
+600.0%
2,000
+135.3%
0.02%
+400.0%
Q3 2019$3,000
-76.9%
8500.0%0.00%
-75.0%
Q2 2019$13,000
-38.1%
8500.0%0.02%
-42.9%
Q1 2019$21,000
+40.0%
8500.0%0.03%
-3.4%
Q4 2018$15,000
-40.0%
8500.0%0.03%
+16.0%
Q3 2018$25,000
-63.2%
850
-43.3%
0.02%
-64.8%
Q2 2018$68,000
-13.9%
1,5000.0%0.07%
-22.0%
Q1 2018$79,000
-35.2%
1,500
-16.7%
0.09%
-34.1%
Q4 2017$122,000
-27.8%
1,800
-12.2%
0.14%
-31.0%
Q3 2017$169,000
-99.7%
2,050
+272.7%
0.20%
+239.0%
Q2 2017$51,497,000
+47.1%
5500.0%0.06%
+37.2%
Q1 2017$35,019,000
-16.4%
550
-45.0%
0.04%
-2.3%
Q4 2016$41,900,000
+16.2%
1,0000.0%0.04%
-4.3%
Q3 2016$36,050,000
+209.1%
1,000
+17.6%
0.05%
+206.7%
Q2 2016$11,662,000
-39.3%
850
-15.0%
0.02%
-42.3%
Q1 2016$19,200,000
-97.6%
1,000
-95.6%
0.03%
-97.4%
Q4 2015$801,850,000
-55.7%
22,910
+16.3%
1.01%
-56.7%
Q3 2015$1,811,612,000
+67.6%
19,700
+60.2%
2.33%
+90.3%
Q2 2015$1,080,924,000
+720.4%
12,300
+593.0%
1.22%
+659.0%
Q1 2015$131,758,000
+32.6%
1,7750.0%0.16%
+24.8%
Q4 2014$99,400,0001,7750.13%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q4 2014
NameSharesValueWeighting ↓
Coppell Advisory Solutions LLC 229$11,0080.00%
View complete list of CLOVIS ONCOLOGY INC shareholders